Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) | SANOFI PASTEUR | UNK | — | OT |
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | UNK | — | — |
they administered Fluzone to a 65 year old patient instead of Fluzone HD with no adverse event; Initial information received on 22-Sep-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 65 year old and unknown gender patient was administered with Influenza Usp Trival A-B Subvirion No Preservative Vaccine [Fluzone] Instead Of Influenza Usp Trival A-B High Dose Subvirion Vaccine [Fluzone High Dose] with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect Influenza Usp Trival A-B Subvirion No Preservative Vaccine Suspension for injection (lot number, strength and expiry date-unknown) via unknown route in unknown administration site for prophylactic vaccination (Immunisation) instead of Influenza Usp Trival A-B High Dose Subvirion Vaccine with no adverse event (wrong product administered) (latency-same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.